South Korean drugmaker Celltrion sets sights on China
SEOUL — After successfully penetrating the European market, South Korean pharmaceutical company Celltrion has set its sights on a new target: China. Celltrion is poised to break into the Chinese market as early as 2020 via a joint venture that will allow it to sell biopharmaceuticals in the world’s most-populous market. This and other global …
South Korean drugmaker Celltrion sets sights on China Read More »